Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide

Fig. 1

Experimental design. Female Balb/C mice were immunized with different amounts of P467 and P647 hybrid peptides, conjugated to either CRM or virosomes (1a; Experiment-I), or with different amounts of P467-CRM administered together with Alum or Montanide (1b; Experiment-II). For examining the kinetic of the immune responses, additional blood samples were taken in two months intervals for the period of 6 months after the last immunization. The occasions for immunization (black arrows) and bleeding (grey arrows) are indicated

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us